telmisartan has been researched along with Prediabetic State in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, TS; Kim, BK; Kim, JY; Lee, CJ; Lee, SH; Park, S; Sung, JH | 1 |
| DiNicolantonio, JJ; Elisaf, MS; Liberopoulos, EN; Rizos, CV; Tellis, K; Tselepis, AD | 1 |
| Cheng, S; Li, H; Li, J; Li, X; Yuan, L | 1 |
2 trial(s) available for telmisartan and Prediabetic State
| Article | Year |
|---|---|
Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial.
Topics: Amlodipine; Atherosclerosis; Cardiovascular Diseases; Fasting; Glucose; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Insulin Resistance; Prediabetic State; Rosuvastatin Calcium; Telmisartan | 2022 |
Combining rosuvastatin with angiotensin-receptor blockers of different PPARĪ³-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Angiotensin II Type 1 Receptor Blockers; Aryldialkylphosphatase; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Cholesterol, HDL; Drug Therapy, Combination; Dyslipidemias; Female; Fluorobenzenes; Greece; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Irbesartan; Lipoproteins, HDL; Male; Middle Aged; PPAR gamma; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan; Tetrazoles; Treatment Outcome | 2015 |
1 other study(ies) available for telmisartan and Prediabetic State
| Article | Year |
|---|---|
Blockade of renin angiotensin system increased resistance to STZ-induced diabetes in rats with long-term high-fat diet.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Diet, High-Fat; Glucose Clamp Technique; Immunohistochemistry; Inflammation Mediators; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-1beta; Male; NF-kappa B; Prediabetic State; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Telmisartan; Time Factors | 2012 |